Hipoxemia refractaria durante la terapia de eliminación extracorpórea de CO2: informe de un caso y revisión de la literatura

Abstract

Extracorporeal carbon dioxide removal is increasingly used in clinical practice as a means of facilitating protective mechanical ventilation and reducing the risk of ventilator-induced lung injury in patients with acute respiratory distress syndrome. In some cases, however, extracorporeal carbon dioxide removal can worsen hypoxaemia due to various pathophysiological mechanisms that need to be taken into consideration. We report a case of refractory hypoxaemia that required interruption of extracorporeal carbon dioxide removal therapy.